Bafna Pharmaceuticals Ltd (BAFNAPH) Shareholding Pattern - Promoter, FII, DII & Public Holdings
As of Jun 2026, promoters held 75% of Bafna Pharmaceuticals Ltd, FIIs 9.34%, DIIs -, government - and the public 15.66%, across 7,062 shareholders.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 88.29% | 88.29% | 75% | 75% | 75% | 75% | 75% | 75% |
| FIIs | 0% | 0% | 8.53% | 9.34% | 9.34% | 9.34% | 9.34% | 9.34% |
| Public | 11.7% | 11.7% | 16.47% | 15.66% | 15.66% | 15.66% | 15.66% | 15.66% |
| No. of Shareholders | 7,295 | 7,214 | 7,142 | 7,283 | 7,572 | 7,119 | 6,928 | 7,062 |